US 7553931
Complement depletion using recombinant human C3-derivatives
granted A61KA61K38/00A61P
Quick answer
US patent 7553931 (Complement depletion using recombinant human C3-derivatives) held by PLS-Design GmbH expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PLS-Design GmbH
- Grant date
- Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P11/06